Increasing prevalence of antimicrobial resistance among Enterobacteriaceae uropathogens in Dakar, Senegal: A multicenter study

Diagnostic Microbiology and Infectious Disease

Volumn 47, Issue 4, 2003, Pages 595-600

  Dromigny, Jacques Albert ^a   Ndoye, Babacar ^b   Macondo, Edgard Adam ^c   Nabeth, Pierre ^a   Siby, Tidiane ^c   Perrier Gros Claude, Jean David ^a  

^a INSTITUT PASTEUR DE DAKAR   (Senegal)

^b HÔPITAL PRINCIPAL DE DAKAR   (Senegal)

^c Laboratoire Bio24   (Senegal)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; COTRIMOXAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD; CITROBACTER FREUNDII; CITROBACTER KOSERI; COMMUNICABLE DISEASE; CONTROLLED STUDY; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROBACTER SAKAZAKII; ENTEROBACTERIACEAE; ESCHERICHIA COLI; EVALUATION; FEMALE; HUMAN; INFANT; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MORGANELLA MORGANII; MULTIDRUG RESISTANCE; NEWBORN; NONHUMAN; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROTEUS MIRABILIS; PROVIDENCIA RETTGERI; SENEGAL; URINALYSIS; URINARY TRACT INFECTION;

EID: 0347986544     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(03)00155-X     Document Type: Article

References (34)

1. Ahmed A.A., Osman H., Mansour A.M., Musa H.A., Ahmed A.B., Karrar Z., Hassan H.S. Antimicrobial agent resistance in bacterial isolates from patients with diarrhea and urinary tract infection in the Sudan. Am J Trop Med Hyg. 63:2000;259-263.
2. Anagonou S.Y., Eslahpazire J., Makoutode M., Josse R., Massougbodji A., Sadeler B.C. Sensibilité aux antibiotiques de bacilles à gram négatif isolés d'infections urinaires au CHNU de Cotonou (Bénin) de mars à décembre 1992. Bull Soc Pathol Exot. 87:1994;223-225.
3. Baerheim A., Digranes A., Hunskaar S. Are resistance patterns in uropathogens published by microbiological laboratories valid for general practice? Acta Pathol Microbiol Immunol Scand. 107:1999;676-680.
4. Baerheim A. Empirical treatment of uncomplicated cystitis. BMJ. 323:2001;1197-1198.
5. Barrett S.P., Savage M.A., Rebec M.P., Guyot A., Andrews N., Shrimpton S.B. Antibiotic sensitivity of bacteria associated with community-acquired urinary tract infection in Britain. J Antimicrob Chemother. 44:1999;359-365.
6. Bosu W.K., Acquah S. Susceptibility of urinary tract to antibiotics in Cape Coast, Ghana. East Afr Med J. 73:1996;468-470.
7. Cardinale, E., Dromigny, J. A., Tall, F., Ndiaye, M., Konte, M., Perrier-Gros-Claude, J. D. (2003). Fluoroquinolones susceptibility of Campylobacter strains isolated from chicken in Senegal. EID (in press).
8. Comité de l'Antibiogramme de la Société Française de Microbiologie. Communiqué officiel. Pathol Biol. 47:1999;845-872.
9. Chomarat M. Resistance of bacteria in urinary tract infections. Int J Antimicrob Agents. 16:2000;483-487.
10. Cormican M., Morris D., Corbett-Feeney G., Flynn J. Extended Spectrum Beta-Lactamase production and fluoroquinolone resistance in pathogens associated with community acquired urinary tract infection. Diagn Microbiol Infect Dis. 32:1998;317-319.
11. Dagnra A.Y., Prince-David M., Hounkpati A. Activité antimicrobienne de la ciprofloxacine et de la nétilmicine comparée à celle de divers antibiotiques à Lomé, Togo. Santé 11:2001;63-66.
12. Diadhiou F., Mboup S., Koly F., Boye C.S., Moreau J.C. Les infections urinaires en pratique gynéco-obstétricale au CHU de Dakar. Dakar Méd. 35:1990;1-9.
13. Dromigny J.A., Nabeth P., Perrier Gros Claude J.D. Distribution and susceptibility of bacterial urinary tract infections in Dakar, Senegal. Int J Antimicrob Agents. 20:2002;339-347.
14. Fassin D. llicit sale of pharmaceuticals in Africa sellers and clients in the suburbs of Dakar . Trop Geogr Med. 40:(2):1988;166-170.
15. Garau J., Xercavins M., Rodriguez-Carballeira M., Gomez-Vera J.R., Coll I., Vidal D., Llovet T., Ruiz-Bremon A. Emergence and dissemination of quinolone-resistant Escherichia coli in the community. Antimicrob Agents Chemother. 43:1999;2736-2741.
16. Goldstein F.W. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Eur J Clin Microbiol Infect Dis. 19:2000;112-117.
17. Gupta K., Scholes D., Stamm W.E. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA. 281:1999;736-738.
18. Henquell C., Sirot D., Chanal C., De Champs C., Chatron P., Lafeuille B., Texier P., Sirot J., Cluzel R. Frequency of inhibitor-resistant TEM beta-lactamases in Escherichia coli isolates from urinary tract infections in France. J Antimicrob Chemother. 34:1994;707-714.
19. Jones R.N., Kugler K.C., Pfaller M.A., Winokur P.L. Characteristics of pathogens causing urinary tract infections in hospitals in North America Results from the SENTRY antimicrobial surveillance program . Diagn Microbiol Infect Dis. 35:1999;55-63.
20. Lehn N., Stower-Hoffmann J., Kott T., Strassner C., Wagner H., Kronke M., Schneider-Brachert W. Characterization of clinical isolates of Escherichia coli showing high levels of fluoroquinolone resistance. J Clin Microbiol. 34:1996;597-602.
21. Malonza I.M., Omari M.A., Bwayo J.J., Mwatha A.K., Mutere A.N., Murage E.M., Ndinya-Achola J.O. Community acquired bacterial infections and their antimicrobial susceptibility in Nairobi, Kenya. East Afr Med J. 74:1997;166-170.
22. Onifade E.O., Nwobu R.A., Bamidele E.O., Okanume C.A. Pathogens and antibiotic susceptibility profiles in the urinary tract. East Afr Med J. 69:1992;587-590.
23. Péan Y., Goldstein F.W., De Bels F. Evolution de la sensibilité et épidémiologie de la résistance des entérobactéries de ville au cours des enquêtes Vigil'Roc. Med Mal Infect. 31:2001;609-621.
24. Pena C., Albareda J.M., Pallares R., Pujol M., Tubau F., Ariza J. Relationship between quinolone use and emergence of ciprofloxacin-resistant Escherichia coli in bloodstream infections. Antimicrob Agents Chemother. 39:1995;520-524.
25. Sahm D.F., Thornsberry C., Mayfield D.C., Jones M.E., Karlowsky J.A. Multidrug-resistant urinary tract isolates of Escherichia coli prevalence and patient demographics in the United States in 2000 . Antimicrob Agents Chemother. 45:2001;1402-1406.
26. Salyers A.A., Amabile-Cuevas C.F. Why are antibiotic resistance genes so resistant to elimination? Antimicrob Agents Chemother. 41:1997;2321-2325.
27. Sotto A., De Boever C.M., Fabbro-Peray P., Gouby A., Sirot D., Jourdan J. Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections a prospective study . J Clin Microbiol. 39:2001;438-444.
28. Sow A.I., Diop N., Ndour C.T., Soumare M., Seydi M., Cisse M.F., Samb A. Infections du tractus urinaire à Dakar Etiologies, bases thérapeutiques . Dakar Méd. 45:2000;59-61.
29. Stapleton P., Wu P.J., King A., Shannon K., French G., Phillips I. Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli. Antimicrob Agents Chemother. 39:1995;2478-2483.
30. Warren J.W., Abrutyn E., Hebel R., Johnson J.R., Schaeffer A.J., Stamm W.E. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Inf Dis. 29:1999;745-758.
31. Weber P., Scotto M., Plaisance J.J., Mancy J., Chouteau J., Chef F., Labia R. Activité in vitro de l'amoxicilline-acide clavulanique vis à vis d'Escherichia coli en médecine de ville. Med Mal Inf. 25:1995;593-598.
32. Winstanley T.G., Limb D.I., Eggington R., Hancock F. A 10 year survey of the antimicrobial susceptibility of urinary tract isolates in the UK The Microbe Base Project . J Antimicrob Chemother. 40:1997;591-594.
33. Wolday D., Erge W. Increased incidence of resistance to antimicrobials by urinary pathogens isolated at Tikur Anbessa Hospital. Ethiop Med J. 35:1997;127-135.
34. Zhanel G.G., Karlowsky J.A., Harding G.K., Carrie A., Mazzulli T., Low D.E., Hoban D.J. A Canadian national surveillance study of urinary tract isolates from outpatients comparison of the activities of trimethoprim- sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group . Antimicrob Agents Chemother. 44:2000;1089-1092.